Related Experiment Video
Updated: Nov 18, 2025

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis
Yanbin Du1, Nan Zhou2, Wenting Zha2
1MOE-LCSM, School of Mathematics and Statistics, Hunan Normal University, Changsha, Hunan Province, 410081, China.
Insights
Hypertension significantly increases the risk of critical COVID-19 and mortality. This meta-analysis confirms hypertension as an independent risk factor for severe coronavirus disease-2019 outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Hypertension is a common comorbidity potentially linked to adverse outcomes in COVID-19 patients.
- Previous studies suggest a correlation, but confounding factors necessitate further investigation into hypertension's independent role.
Purpose of the Study:
- To determine if hypertension is an independent risk factor for critical illness and mortality in COVID-19 patients.
- To quantify the risk associated with hypertension in the context of COVID-19 severity and fatality.
Main Methods:
- Systematic literature search of Medline, PubMed, Embase, and Web of Science databases up to November 2020.
- Meta-analysis of 24 observational studies involving 99,918 COVID-19 patients.
- Random-effects models used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs); subgroup and meta-regression analyses performed.
Main Results:
- Hypertension prevalence was higher in critical COVID-19 (37%) and deceased patients (46%) compared to non-critical (18%) and survivor groups (22%).
- Patients with hypertension showed a 1.82-fold increased risk for critical COVID-19 (aOR: 1.82) and a 2.17-fold increased risk for mortality (aOR: 2.17).
- Subgroup analysis indicated higher risk for males and individuals over 60 years; meta-regression confirmed age's significant influence on the hypertension-mortality association.
Conclusions:
- Hypertension is an independent risk factor associated with significantly increased risks of critical COVID-19.
- The findings highlight hypertension as a key predictor of severe outcomes and mortality in coronavirus disease-2019.
- Age and sex are important covariates influencing the risk of severe COVID-19 in hypertensive patients.
Aims:
As reported, hypertension may play an important role in adverse outcomes of coronavirus disease-2019 (COVID-19), but it still had many confounding factors. The aim of this study was to explore whether hypertension is an independent risk factor for critical COVID-19 and mortality.
Data Synthesis:
The Medline, PubMed, Embase, and Web of Science databases were systematically searched until November 2020. Combined odds ratios (ORs) with their 95% confidence interval (CIs) were calculated by using random-effect models, and the effect of covariates was analyzed using the subgroup analysis and meta-regression analysis. A total of 24 observational studies with 99,918 COVID-19 patients were included in the meta-analysis. The proportions of hypertension in critical COVID-19 were 37% (95% CI: 0.27 -0.47) when compared with 18% (95% CI: 0.14 -0.23) of noncritical COVID-19 patients, in those who died were 46% (95%CI: 0.37 -0.55) when compared with 22% (95% CI: 0.16 -0.28) of survivors. Pooled results based on the adjusted OR showed that patients with hypertension had a 1.82-fold higher risk for critical COVID-19 (aOR: 1.82; 95% CI: 1.19 - 2.77; P = 0.005) and a 2.17-fold higher risk for COVID-19 mortality (aOR: 2.17; 95% CI: 1.67 - 2.82; P < 0.001). Subgroup analysis results showed that male patients had a higher risk of developing to the critical condition than female patients (OR: 3.04; 95%CI: 2.06 - 4.49; P < 0.001) and age >60 years was associated with a significantly increased risk of COVID-19 mortality (OR: 3.12; 95% CI: 1.93 - 5.05; P < 0.001). Meta-regression analysis results also showed that age (Coef. = 2.3×10-2, P = 0.048) had a significant influence on the association between hypertension and COVID-19 mortality.
Conclusions:
Evidence from this meta-analysis suggested that hypertension was independently associated with a significantly increased risk of critical COVID-19 and inhospital mortality of COVID-19.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension II: Pathophysiology
Measurement of Blood Pressure
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management

